Øyvind Sverre Bruland • 1952 • Oslo • 8 roles • 4 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
B BLAAHAUGEN AS	Managing Director/CEO	862,566	13,347,560	100 % directly

Boards

Name	Role	Total operating income	Total equity	Shares
B BLAAHAUGEN AS	Chairman	862,566	13,347,560	100 % directly
S SRB RADIOPHARMA HOLDING AS	Board Member	-	14,955,724	5.62 % indirectly
N NUCLITHERA AS	Alternate Member	250,000	1,374,758	4 % indirectly
O ONCOSYNE AS	Board Member	1,656,989	5,197,039	-
A ARTBIO AS	Observer	60,439,239	17,199,482	-
L LYSEBRÅTEN - BERGENDAL VEIVEDLIKEHOLDSFORENING	Chairman	-	-	-

Last update: Jul 1, 2024

Related industries3

Professional, scientific and technical activities
Human health and social work activities
Real estate activities

Direct relationships5

RH
Roy Hartvig Larsen1962
BLAAHAUGEN AS, ARTBIO AS, SRB RADIOPHARMA HOLDING AS, NUCLITHERA AS
AT
Anders Tuv1978
ARTBIO AS, SRB RADIOPHARMA HOLDING AS
JE
John Edvard Karlsrud1974
ONCOSYNE AS
JM
Janne Merethe Nestvold1963
ONCOSYNE AS
BT
Bengt Thomas Andersson1952
ONCOSYNE AS

Shares owned by Øyvind Sverre Bruland

Name	Share class	Total operating income	Total equity	Share
B BLAAHAUGEN AS	Ordinære aksjer	862,566	13,347,560	100 % directly
S SRB RADIOPHARMA HOLDING AS		0	14,955,724	5.62 % indirectly
N NUCLITHERA AS		250,000	1,374,758	4 % indirectly
O ONCOINVENT ASA		5,790,000	54,931,000	3.26 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: May 24, 2024